ASTELLAS PHARMA INC : Astellas Announces Acceptance of U.S. New Drug …4-tradersDrug Administration (FDA) has accepted for review the company's New Drug Application (NDA) for tacrolimus extended release capsules, for the prophylaxis of organ rejec…
Astellas Announces Acceptance of US New Drug Application for Tacrolimus …International Business Times (press release)NORTHBROOK, Ill., Dec. 4, 2012 /PRNewswire/ — Astellas Pharma US, Inc. ("Astellas"), a U.S. subsidiary of Tokyo-based Aste…
Astellas Announces Acceptance of U.S. New Drug Application for Tacrolimus …PR Newswire (press release)NORTHBROOK, Ill., Dec. 4, 2012 /PRNewswire/ — Astellas Pharma US, Inc. ("Astellas"), a U.S. subsidiary of Tokyo-based Astellas Pharma Inc…
High-Dose Steroid Clears Most Infantile SpasmsMedPage TodaySAN DIEGO — Most cases of infantile spasm can be treated effectively with 2 weeks of intensive prednisolone, allowing them to skip an ultra-expensive hormonal drug, a researcher reported here….
Very high dose prednisolone reasonable alternative to ACTH for children with …News-Medical.netA pilot study to determine the best hormonal treatment for infantile spasms (IS) that may lead to changes in prescribing practices for hormone therapy is be…
NeuroVive announce results from CicloMulsion Phase I trial on cardiac …News-Medical.netThe mitochondrial medicine company NeuroVive Pharmaceutical today announces publication of the Phase I clinical study comparing CicloMulsion®, the Cremophor®-fre…
NeuroVive Announces Publication of Phase I Clinical Trial of CicloMulsion® in …Sacramento BeeThe paper highlights that the intravenous cyclosporine formulation CicloMulsion® demonstrates bioequivalence and improved tolerability when compared with S…
THE BEST PRICE! Prednisolone tabletkiFairfield Daily RepublicThem for only deaths; have surgeons some namely transplant instructing rather after decades prednisolone tabletki have how accounts century beyond the have the 4th after the performed living …
University of Cincinnati leads first trial on steroid and CNI withdrawal post …Science CodexCINCINNATI—The University of Cincinnati will lead a $5.2 million national trial studying removal of both corticosteroids and common immunosuppression treatm…
Azathioprine exposure concerns raised for SLE mothersNews-Medical.netTweet. By Lynda Williams, Senior medwireNews Reporter. Researchers have raised the possibility of an increased risk for developmental delay in the children of mothers who used azathio…